Deutsche Bank’s Syneron Medical Ltd ELOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-46,781
| Closed | -$512K | – | 5317 |
|
|
2017
Q2 | $512K | Sell |
46,781
-385,011
| -89% | -$4.22M | ﹤0.01% | 3436 |
|
|
2017
Q1 | $4.55M | Buy |
431,792
+10,300
| +2% | +$99.6K | ﹤0.01% | 1735 |
|
|
2016
Q4 | $3.54M | Buy |
421,492
+38,969
| +10% | +$305K | ﹤0.01% | 1887 |
|
|
2016
Q3 | $2.74M | Sell |
382,523
-71,450
| -16% | -$497K | ﹤0.01% | 2140 |
|
|
2016
Q2 | $3.49M | Sell |
453,973
-63,198
| -12% | -$451K | ﹤0.01% | 2019 |
|
|
2016
Q1 | $3.78M | Sell |
517,171
-16,700
| -3% | -$120K | ﹤0.01% | 1943 |
|
|
2015
Q4 | $4.12M | Buy |
533,871
+24,847
| +5% | +$189K | ﹤0.01% | 1926 |
|
|
2015
Q3 | $3.64M | Sell |
509,024
-5,686
| -1% | -$54.6K | ﹤0.01% | 2028 |
|
|
2015
Q2 | $5.47M | Buy |
514,710
+9,910
| +2% | +$116K | ﹤0.01% | 1739 |
|
|
2015
Q1 | $6.25M | Buy |
504,800
+106,507
| +27% | +$1.18M | ﹤0.01% | 1646 |
|
|
2014
Q4 | $3.71M | Buy |
398,293
+5,164
| +1% | +$49.8K | ﹤0.01% | 2196 |
|
|
2014
Q3 | $3.94M | Sell |
393,129
-6,926
| -2% | -$70.5K | ﹤0.01% | 2007 |
|
|
2014
Q2 | $4.13M | Sell |
400,055
-48,430
| -11% | -$524K | ﹤0.01% | 1954 |
|
|
2014
Q1 | $5.58M | Sell |
448,485
-33,977
| -7% | -$402K | ﹤0.01% | 1737 |
|
|
2013
Q4 | $5.93M | Sell |
482,462
-4,100
| -0.8% | -$42.6K | ﹤0.01% | 1655 |
|
|
2013
Q3 | $4.19M | Buy |
486,562
+98,664
| +25% | +$852K | ﹤0.01% | 1951 |
|
|
2013
Q2 | $3.37M | Buy |
+387,898
| New | +$3.47M | ﹤0.01% | 1866 |
|
Other funds holding ELOS
Deutsche Bank's ELOS Position: Q3 2017 in Review
Deutsche Bank sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 46,781 shares — an estimated $512K sold.
Deutsche Bank first reported a position in ELOS in Q2 2013 and held it in 17 quarters. The position peaked at $6.25M in Q1 2015. 3 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.
- Deutsche Bank reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
- Deutsche Bank sold 46,781 Syneron Medical Ltd shares in Q3 2017, an estimated $512K.
- Deutsche Bank first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 17 quarters.
- Deutsche Bank's Syneron Medical Ltd position peaked at $6.25M in Q1 2015.
- 3 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.
Based on Deutsche Bank's 13F filing for Q3 2017, filed 14 Nov 2017.